tezosentan has been researched along with Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beier, UH; Chin, A; Fornell, L; John, E; Pham, J; Radhakrishnan, J; Samuel, S | 1 |
| Anselmo, D; Busuttil, RW; Clozel, M; Farmer, DG; Kaldas, F; Kaldas, M; Katori, M; Kupiec-Weglinski, J; Lassman, C; Shen, XD | 1 |
| Robinson, AV; Schulak, JA; Stowe, NT; Wilhelm, SM | 1 |
3 other study(ies) available for tezosentan and Ischemia
| Article | Year |
|---|---|
The effect of tezosentan after cold ischemia and renal artery clamping as a model of reperfusion injury in newborn piglets.
Topics: Animals; Animals, Newborn; Blood Flow Velocity; Cardiovascular System; Disease Models, Animal; Femoral Artery; Heart Rate; Ischemia; Pyridines; Renal Artery; Reperfusion Injury; Swine; Tetrazoles; Vasodilator Agents | 2008 |
Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.
Topics: Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Hemodynamics; Ischemia; Liver; Liver Transplantation; Male; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tetrazoles; Warm Ischemia | 2008 |
The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function.
Topics: Animals; Endothelin Receptor Antagonists; Endothelin-1; Glomerular Filtration Rate; Immunohistochemistry; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Male; Pyridines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Tetrazoles; Time Factors | 2001 |